FEATURED NEWS

• HDA Statement on “Connecticut Option” Proposal

  May 24, 2019

  The Healthcare Distribution Alliance (HDA) issued a statement in response to the proposed “Connecticut Option,” which imposes an assessment on the first sale of prescription opioids.

• Suspicious Order Reporting and Prescription Opioid Medications

  May 22, 2019

  As the logistics experts of the pharmaceutical supply chain, distributors have developed advanced security and monitoring systems to make sure that the medications they handle and transport are authentic and legitimate; secured throughout delivery to avoid tampering or diversion; and received by licensed pharmacies and healthcare providers across the country.

• HDA Statement on Minnesota Senate Passage of HF 400

  May 21, 2019

  The Healthcare Distribution Alliance (HDA) issued a statement in response to the Minnesota Senate’s passage of HF 400, which imposes annual fees on prescription opioid manufacturers and distributors.

• HDA Initiative to Highlight Value Distributors Provide to the Healthcare System

  May 16, 2019

  Today, the Healthcare Distribution Alliance (HDA) announced the launch of a new initiative highlighting pharmaceutical distributors’ critical role in the safe, reliable and efficient delivery of medical products to hundreds of thousands of pharmacies, hospitals and other healthcare providers nationwide. The initiative focuses on the work distributors undertake every day, even during the most challenging times, in collaboration with partners across the pharmaceutical supply chain.

• Supply Chain Security Leaders Honored at HDA's PCSC Educational Seminar

  May 9, 2019

  HDA’s Pharmaceutical Cargo Security Coalition (PCSC) recognized three security professionals for their dedication to the industry today at the PCSC Educational Seminar in East Hanover, N.J. The PCSC Award acknowledges leaders who have exhibited extraordinary standards of honesty and integrity while working tirelessly to protect and serve their communities.